|
|
||||||||
ORIGINAL CONTRIBUTION |
|
Department of Cardiovascular Surgery and Cardiology Hôpital de la Tour Geneva, Switzerland |
| For reprint information contact: Jan T Christenson, MD Tel: 41 22 372 7872 Fax: 41 22 372 7634 email: jtchristenson{at}hotmail.com Department of Surgery, Clinic for Cardiovascular and Thoracic Surgery, University Hospital, rue Micheli-du-Crest 24, Geneva 14 CH-1211, Switzerland. |
6.2 mmolL1 (n = 40); group B, cholesterol < 6.2 but
5.2 mmolL1 (n = 22); group C, cholesterol < 5.2 but
4.7 (n = 18); and group D, cholesterol < 4.7 mmolL1 (n = 50). Patient demo-graphics, angiography findings, and operative data did not differ between the groups. The incidence of postoperative thrombocytosis (platelet count
400,000/µL) was 82.5%, 36.4%, 16.7%, and 2.0% for groups A to D, respectively. Patients who developed thrombocytosis had a significantly higher preoperative ratio of total cholesterol to high-density lipoprotein cholesterol than those with normal platelet counts. The incidence of thrombocytosis directly correlated with the preoperative total cholesterol level. A distinct separation point seems to be a total cholesterol level of 4.7 mmolL1. Preoperative lipid control with statins is emphasized to avoid postoperative thrombocytosis and thrombotic complications. The total cholesterol/high-density lipoprotein cholesterol ratio seems to be the best indicator of the risk of developing postoperative thrombocytosis.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |